+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Safety and Efficacy of Combined Extracorporeal CO2 Removal and Renal Replacement Therapy in Patients With Acute Respiratory Distress Syndrome and Acute Kidney Injury: The Pulmonary and Renal Support in Acute Respiratory Distress Syndrome Study



Safety and Efficacy of Combined Extracorporeal CO2 Removal and Renal Replacement Therapy in Patients With Acute Respiratory Distress Syndrome and Acute Kidney Injury: The Pulmonary and Renal Support in Acute Respiratory Distress Syndrome Study



Critical Care Medicine 43(12): 2570-2581



To assess the safety and efficacy of combining extracorporeal CO2 removal with continuous renal replacement therapy in patients presenting with acute respiratory distress syndrome and acute kidney injury. Prospective human observational study. Patients received volume-controlled mechanical ventilation according to the acute respiratory distress syndrome net protocol. Continuous venovenous hemofiltration therapy was titrated to maintain maximum blood flow and an effluent flow of 45 mL/kg/h with 33% predilution. Eleven patients presenting with both acute respiratory distress syndrome and acute kidney injury required renal replacement therapy. A membrane oxygenator (0.65 m) was inserted within the hemofiltration circuit, either upstream (n = 7) or downstream (n = 5) of the hemofilter. Baseline corresponded to tidal volume 6 mL/kg of predicted body weight without extracorporeal CO2 removal. The primary endpoint was 20% reduction in PaCO2 at 20 minutes after extracorporeal CO2 removal initiation. Tidal volume was subsequently reduced to 4 mL/kg for the remaining 72 hours. Twelve combined therapies were conducted in the 11 patients. Age was 70 ± 9 years, Simplified Acute Physiology Score II was 69 ± 13, Sequential Organ Failure Assessment score was 14 ± 4, lung injury score was 3 ± 0.5, and PaO2/FIO2 was 135 ± 41. Adding extracorporeal CO2 removal at tidal volume 6 mL/kg decreased PaCO2 by 21% (95% CI, 17-25%), from 47 ± 11 to 37 ± 8 Torr (p < 0.001). Lowering tidal volume to 4 mL/kg reduced minute ventilation from 7.8 ± 1.5 to 5.2 ± 1.1 L/min and plateau pressure from 25 ± 4 to 21 ± 3 cm H2O and raised PaCO2 from 37 ± 8 to 48 ± 10 Torr (all p < 0.001). On an average of both positions, the oxygenator's blood flow was 410 ± 30 mL/min and the CO2 removal rate was 83 ± 20 mL/min. The oxygenator blood flow (p <0.001) and the CO2 removal rate (p = 0.083) were higher when the membrane oxygenator was placed upstream of the hemofilter. There was no safety concern. Combining extracorporeal CO2 removal and continuous venovenous hemofiltration in patients with acute respiratory distress syndrome and acute kidney injury is safe and allows efficient blood purification together with enhanced lung protective ventilation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058801859

Download citation: RISBibTeXText

PMID: 26488219

DOI: 10.1097/ccm.0000000000001296


Related references

Assessing Feasibility (and Increasing Simplicity) in Extracorporeal Rescue Therapy for Acute Respiratory Distress Syndrome: The Pulmonary and Renal Support in Acute Respiratory Distress Syndrome Study. Critical Care Medicine 43(12): 2683-2685, 2016

Extracorporeal CO 2 Removal May Improve Renal Function of Patients with Acute Respiratory Distress Syndrome and Acute Kidney Injury: An Open-Label, Interventional Clinical Trial. American Journal of Respiratory and Critical Care Medicine 198(5): 687-690, 2018

Acute lung injury and acute respiratory distress syndrome: extracorporeal life support and liquid ventilation for severe acute respiratory distress syndrome in adults. Seminars in Respiratory and Critical Care Medicine 27(4): 416-425, 2006

Efficacy of continuous renal replacement therapy in the treatment of severe acute pancreatitis associated acute respiratory distress syndrome. European Review for Medical and Pharmacological Sciences 18(17): 2523-2526, 2015

Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support. Annals of Intensive Care 7(1): 82, 2017

Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review. Critical Care 18(3): 222, 2015

Acute lung injury/acute respiratory distress syndrome: progress in diagnosis and treatment topics: I. Pathogenesis and pathophysiology; 1. The concept and definitions of acute lung injury and acute respiratory distress syndrome. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 100(6): 1518-1521, 2011

Renal replacement therapy in patients with acute respiratory distress syndrome: a single-center retrospective study. International Journal of Nephrology and Renovascular Disease 11: 249-257, 2018

Acute lung injury/acute respiratory distress syndrome: progress in diagnosis and treatment. Topics: III. Treatment; 2. Current status and future direction of pharmacological treatments for acute respiratory distress syndrome. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 100(6): 1575-1581, 2011

Does acute kidney injury affect survival in adults with acute respiratory distress syndrome requiring extracorporeal membrane oxygenation?. Perfusion 33(5): 375-382, 2018

Efficacy of statin therapy in patients with acute respiratory distress syndrome/acute lung injury: a systematic review and meta-analysis. European Review for Medical and Pharmacological Sciences 22(10): 3190-3198, 2018

Early extracorporeal life support as rescue therapy for severe acute respiratory distress syndrome after inhalation injury. Journal of Burn Care and Research 30(6): 1035-1038, 2010

Early initiation of continuous renal replacement therapy improves clinical outcomes in patients with acute respiratory distress syndrome. American Journal of the Medical Sciences 349(3): 199-205, 2015

Surfactant Replacement Therapy in Pediatric Acute Lung Injury/Acute Respiratory Distress Syndrome. Current Respiratory Medicine Reviews 5(3): 160-167, 2009

Evolution of leukotriene B4, peptide leukotrienes, and interleukin-8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: mortality prognostic study. Critical Care Medicine 28(1): 57-62, 2000